The etiology of the highly myopic condition has been unclear for decades. We investigated the genetic contributions to early-onset high myopia (EOHM), which is defined as having a refraction of less than or equal to −6 diopters before the age of 6, when children are less likely to be exposed to high educational pressures. Trios (two nonmyopic parents and one child) were examined to uncover pathogenic mutations using whole-exome sequencing. We identified parent-transmitted biallelic mutations or de novo mutations in asyet-unknown or reported genes in 16 probands. Interestingly, an increased rate of de novo mutations was identified in the EOHM patients. Among the newly identified candidate genes, a BSG mutation was identified in one EOHM proband. Expanded screening of 1,040 patients found an additional four mutations in the same gene. Then, we generated Bsg mutant mice to further elucidate the functional impact of this gene and observed typical myopic phenotypes, including an elongated axial length. Using a trio-based exonic screening study in EOHM, we deciphered a prominent role for de novo mutations in EOHM patients without myopic parents. The discovery of a disease gene, BSG, provides insights into myopic development and its etiology, which expands our current understanding of high myopia and might be useful for future treatment and prevention.
The etiology of the highly myopic condition has been unclear for decades. We investigated the genetic contributions to early-onset high myopia (EOHM), which is defined as having a refraction of less than or equal to −6 diopters before the age of 6, when children are less likely to be exposed to high educational pressures. Trios (two nonmyopic parents and one child) were examined to uncover pathogenic mutations using whole-exome sequencing. We identified parent-transmitted biallelic mutations or de novo mutations in asyet-unknown or reported genes in 16 probands. Interestingly, an increased rate of de novo mutations was identified in the EOHM patients. Among the newly identified candidate genes, a BSG mutation was identified in one EOHM proband. Expanded screening of 1,040 patients found an additional four mutations in the same gene. Then, we generated Bsg mutant mice to further elucidate the functional impact of this gene and observed typical myopic phenotypes, including an elongated axial length. Using a trio-based exonic screening study in EOHM, we deciphered a prominent role for de novo mutations in EOHM patients without myopic parents. The discovery of a disease gene, BSG, provides insights into myopic development and its etiology, which expands our current understanding of high myopia and might be useful for future treatment and prevention.
early-onset high myopia | de novo mutations | BSG | rare inherited mutations M yopia is the most common ocular disease, with an increasing global prevalence, especially in East Asia (1) (2) (3) . Uncorrected myopia is the leading cause of vision impairment worldwide, according to a report by the World Health Organization (4) . High myopia (HM) is very severe myopia, which is defined as less than or equal to −6.00 diopters (D) (5) . HM is clinically associated with severe ocular complications, such as macular degeneration, retinal detachment, cataract, and glaucoma, which make HM the leading cause of irreversible blindness in East Asia (1, 6) .
Myopia is etiologically heterogeneous because both environmental factors and genetic factors are involved (1, 7) . Epidemiological surveys show that outdoor activity reduces the prevalence of myopia, decreasing the risk of myopia associated with shortdistance work (8, 9) . Myopia often exhibits apparent familial aggregation (10) (11) (12) , and the number of myopic parents is significantly correlated with myopic onset and progression in children (13) . Twin studies and population-based epidemiological investigations show that genetic factors significantly contribute to the development of myopia (6, 14, 15) , particularly HM (5). Genomewide association studies (GWAS) and subsequent metaanalyses have identified dozens of loci and genes that are associated with general myopia or HM (16, 17) . Of note, the identified genetic contributions of the dozens of loci and genes to myopia are very limited. To date, based on pedigree studies with next-generation sequencing, several disease-causing genes have been discovered, including two recessive genes, LRPAP1 (18) and LEPREL1 (19); four dominant genes, ZNF644 (20), SCO2 (21), SLC39A5 (22) , and P4HA2 (23); and one X-linked gene, ARR3 (24) . However, a large-scale screening of these genes in HM cohorts provided evidence that only a small proportion (<5%) of HM patients harbor mutations in these known genes, which can be attributed to as-yetunidentified causative genes (25) .
Because preschool children encounter fewer risks from environmental pressures, we proposed that the condition of earlyonset high myopia (EOHM) is driven by a genetic predisposition more than by environmental factors. In this study, we recruited 18 familial trios (healthy parents and an EOHM child) to decipher the genetic predisposition using whole-exome sequencing (WES). We identified a cluster of unique genes linked to EOHM, as well as mutations in the reported genes. Notably, we showed that both rare inherited mutations and de novo mutations significantly contributed to EOHM. Expression profiling in ocular tissues and mutant mouse phenotyping demonstrated the
Significance
Because preschool children encounter fewer risks from environmental pressures, we propose that the condition of earlyonset high myopia (EOHM) is driven by a genetic predisposition more than by environmental factors. In this study, we recruited 18 familial trios to decipher the genetic predisposition using whole-exome sequencing. We identified a cluster of unique genes linked to EOHM, as well as mutations in the reported genes. Notably, we showed that both rare inherited mutations and de novo mutations significantly contributed to EOHM. Expression profiling in ocular tissues and mutant mouse phenotyping demonstrated the pathogenicity of mutations in a unique gene, BSG. Our results provide insights into the genetic basis and molecular mechanisms of childhood high myopia. pathogenicity of the mutations in a unique gene, BSG. Our results provide insights into the genetic basis and molecular mechanisms of childhood HM.
Results EOHM Samples and WES. In this study, we recruited a cohort of 54 individuals, including 18 children with EOHM and their unaffected parents. The ages at examination of all probands were less than 6, indicating EOHM. The refraction of each patient was less than or equal to −6.00 diopters (D) ( Table S1) .
WES was performed for all probands and the parents of the 18 trios to investigate the genetic basis. Burrows-Wheeler transform (26) and Genome Analysis Toolkit (GATK) (27) were used for the data analyses. The detailed statistical information of the WES data from the 18 HM trios is summarized in the Table S2 .
Rare Inherited Mutations in EOHM. Rare inherited mutations cause HM in an autosomal recessive, dominant, or X-linked manner. Based on the sporadic EOHM patients used in this study, we first tried to identify biallelic mutations using mirTrios (28) . We identified two known HM candidate genes (LEPREL1 and GRM6), three oculopathy-related genes (FAM161A, GLA, and CACNA1F), and a further possible gene (MAOA) in six different individuals, which accounted for one-third of the EOHM samples (Dataset S1 and Table S3 ).
In proband H16, we detected a damaging biallelic mutation (p.L530P) in LEPREL1, which is involved in collagen chain assembly, stability, and cross-linking. Mutations in this gene have been reported in patients with HM in western Asia (19, 29) and China (30) . Leprel1 knockout (KO) mice with abnormal collagen chemistry partially recapitulate the myopic changes (31) . Proband H33 carries a homozygous mutation (p.Q708H) in the GRM6 gene. Mutations in GRM6 are reported in HM (32) and nyctalopia (33) . In addition to these two known genes, we identified a unique candidate gene, FAM161A, which is involved in microtubule stabilization (34, 35) . Proband H45 harbors a nonsense mutation (p.Q302X) in FAM161A. Loss-of-function mutations in this gene are reported to cause autosomal recessive retinitis pigmentosa (36, 37) . Interestingly, HM is coupled with these diseases in patients (38) .
In another three unrelated patients, we detected mutations in three candidate genes, including MAOA, GLA, and CACNA1F. A boy (H1) harbored a hemizygous mutation in MAOA (p.V18E), which encodes an oxidative deaminase for amines. It is reported that 5-hydroxytryptamine is involved in the development of retinal ganglion cells (39, 40) . In addition, we identified a hemizygous mutation (p.Y216F) in the galactosidase α (GLA) gene in proband H9. This gene is a known candidate gene for Fabry disease with an ocular pathology (41) and corneal dystrophy (42) . Furthermore, a hemizygous mutation in the CACNA1F gene (p.R1060W) was discovered in proband H29. CACNA1F mutations are reported in patients with HM, congenital stationary night blindness type 2A (43) , cone-rod dystrophy (44) , and nyctalopia (45) .
Contribution of the de Novo Mutation to EOHM. With the exception of the rare inherited mutations described above, we propose that de novo germline mutations may contribute to the genetic architecture of EOHM, which has not been fully studied. Using the Burrows-Wheeler Aligner (BWA)/GATK/mirTrios, we identified a total of 29 de novo single-nucleotide variants (SNVs) within the coding regions. We confirmed that 20 of the 29 de novo SNVs were genuine de novo mutations by direct PCR sequencing, and 17 were identified as nonsynonymous mutations (Dataset S2). Overall, 13 of the 18 probands (72%) carried at least one de novo mutation, and 7 probands harbored (39%) more than two de novo mutations.
The overall de novo mutation rate in the probands (1.11 events per proband on average) was consistent with a background de novo mutation rate of ∼0.91-1.07 that was estimated from previous studies (46) (47) (48) . To determine whether the EOHM probands had elevated de novo mutations compared with the controls, we obtained the de novo mutation rates in the normal individuals from the NPdenovo database (49) . As a result, we found an increased trend of the overall de novo mutation rate in the HM patients (1.11 events per proband on average) compared with that in the normal individuals (0.74 events per individual on average) with an HM/control rate ratio (RR) of 1.51 (P = 0.05) (Fig. 1A) . Interestingly, we observed a significantly elevated de novo missense mutation rate in the patients compared with that in the normal individuals (RR = 1.98, 0.94 vs. 0.48, P = 0.008), and this difference was even greater (RR = 3.74, 0.39 vs. 0.1, P = 0.004) when only the damaging de novo missense mutations were considered. In addition, the number of de novo SNVs in each proband was significantly correlated with the paternal age (r = 0.491, P = 0.019) (Fig. 1B) using a Pearson correlation analysis, which is consistent with previous findings (50, 51) . We correlated the number of de novo mutations detected and the degree of myopic refraction in each eye to analyze the possible direct contributions of the de novo mutations to the HM phenotypes. We observed a trend of a higher degree of myopia as the number of de novo mutations increased (0, one, and two) ( Fig. 1 C and D) .
Candidate Genes with Damaging de Novo Mutations. The detection of recurrent de novo mutations is a commonly used method to identify disease-causing genes. However, in this study, we found that the de novo mutations occurred in different genes in all cases, which prevented us from performing a statistical analysis of any of the specific genes. Therefore, we used 14 bioinformatics tools to predict the damaging effects of all missense de novo mutations detected and identified mutations that were more likely to confer a disease risk (Fig. 1E) . One de novo missense mutation in the EPHB2 gene was identified in proband H42, and the mutation was predicted to be damaging by 10 bioinformatics tools. The EPHB2 gene is involved in retinal axon projections via interactions with ephrin-B proteins (52) . In addition, it was reported that the growth cone collapse and axon retraction of retinal ganglion cells could be induced by EPHB2 gene expression (53) . Therefore, the direct evidence of the contribution of the EPHB2 gene to retinal axon projections suggests that the EPHB2 mutations may be a possible cause of the optical problems observed in the proband. One de novo missense mutation in the CSMD1 gene was identified in proband H70, which is related to several neuron function-related disorders, such as schizophrenia, autism, sclerosis, etc. (54). One de novo missense mutation in the TENM4 gene was identified in proband H1. Notably, the TENM4 gene is also associated with neuron function-related disorders based on the genome sequencing of cases and controls (55) and a GWAS study (56) . In addition, the TENM4 gene is essential for embryonic mesoderm development in mouse model studies (57) . One de novo missense mutation in the BSG gene was identified in proband H13. The BSG gene encodes a photoreceptor-specific transmembrane protein, Basigin, which cross talks with rod-derived cone viability factor (RdCVF) (58, 59 ). The BSG gene will be discussed further in the subsequent sections as a unique candidate gene for EOHM.
Expanded Screening Identified BSG Mutations. A mutation in the BSG gene (c.889G>A, p.G297S) identified in the EOHM patient (Fig. 2) showed strong pathogenicity, according to computational predictions. Moreover, it is completely absent in Exome Variant Server (EVS) and 1000 Genomes Project (1000G) and exhibits a very rare frequency in Exome Aggregation Consortium (ExAC) (1/115742, 8.64e-06). We further screened the entire coding region of the BSG gene in a large cohort of 1,040 unrelated patients with HM, none of which had mutations in the known genes, to determine the replication of the BSG mutations. Interestingly, we also identified one different missense mutation (c.661C>T, p.P221S), one nonsense mutation (c.205C>T, p.Q69X), and one splicing mutation (c.415+1G>A) in the BSG gene (Table 1 and Fig. 2 ) in a total of four unrelated families. All of these mutations were absent in the ExAC database and either led to a protein coding change (c.205C>T, p.Q69X; c.415+1G>A) or displayed strong pathogenicity according to the computational assessment (c.889G>A, p.G297S; c.661C>T, p.P221S). Furthermore, both of the missense mutation (G297S and P221S) sites are located in highly conserved amino acids across different species (Fig. 2) . However, because the parental DNA was unavailable, it is not clear whether these mutations are de novo mutations. Taken together, these results confirmed the recurrence of the BSG mutations by expanded screening in an additional HM cohort, which supported the pathogenicity of this gene for HM.
Bsg Mutant Mice Display Typical Myopic Phenotypes in the Axial
Length. We generated knockin mice (Fig. S1 ) with a c.901G>A mutation corresponding to the c.889G>A mutation identified in the EOHM patient to further investigate the functional impact of the BSG mutation. The total axial length (AL) and vitreous chamber depth (VCD) were measured in variant ages (4, 6, 8, and 10 wk) of the mutant mice and wild-type (WT) siblings. The results showed that the ΔAL significantly changed with group (F = 51.26, P = 1.63e-10) and time (F = 42.36, P = 6.50e-14) overall, and there were no interactions between group and time (F = 2.35, P = 0.1012) (Fig. 3) . The heterozygous mutant group had an increased AL in the subsequent 2 wk compared with the WT group (Tukey multiple comparison, Δmean = 0.015 mm, P < 1e-50). The ΔAL in the subsequent 2 wk also changed with time (peaks at 6 wk, and then the ΔAL decreased slightly). However, there were no significant differences with group (F = 0.47, P = 0.49) and time (F = 1.86, P = 0.16) in ΔVCD (Fig. S2) . The trend of the AL and VCD of the WT mice was consistent with the previous studies as follows: AL increases during postnatal development, whereas the VCD decreases (60, 61) .
To test whether retinal function was affected in the mutant mice, we performed an electroretinogram (ERG). The results showed that both the photopic and scotopic ERG responses of the mutant mice were normal compared with those of their WT siblings (Fig. S3 ). This result indicated that the retinal function was not affected by the Bsg mutation, which was consistent with the clinical manifestation in the patients. Taken together, the results showed that the Bsg mutant mice displayed typical HM phenotypes with a longer AL but no retinal dysfunction.
Spatial Expression Patterns of the Bsg Gene in Mice. Next, we wanted to determine the Bsg expression patterns in different tissues. Therefore, we investigated the spatial expression patterns of Bsg in various mouse tissues. Interestingly, two known myopia-related genes, Sco2 and Sntb1, exhibited patterns similar to that of Bsg (Fig. S4) .
Discussion
Both myopia and HM are etiologically heterogeneous disorders. It is commonly known that both genetic factors and environmental factors contribute to the etiology (1). Population-based epidemiological investigations found that the disease is associated with environmental risk factors, such as a close reading distance and less outdoor activity (8, 9) . With the advent of nextgeneration sequencing, a few of disease genes have been discovered in recent years (18) (19) (20) (21) (22) (23) (24) . Because myopia is dependent on both genetics and lifestyle and preschool children have less exposure to environmental risks, we designed this study using a special cohort with EOHM. Each trio has one EOHM child and two unaffected parents, with or without another unaffected sibling. Through this design, we were able to focus on the genetic cause of the newly created EOHM in each family.
Our study used a trio-based WES strategy to dissect the genetic basis of EOHM. Based on WES and the subsequent validation, we deciphered the genetic causes of 4 known genes and discovered 12 unique candidate genes. A total of 16 biallelic or de novo mutations were identified in the present study. To date, cohort-based genetic studies have identified several genes that contribute to myopic development. Jiang et al. (25) comprehensively screened the LRPAP1, CTSH, LEPREL1, ZNF644, SLC39A5, and SCO2 genes in 298 families with EOHM and identified potential pathogenic mutations in 9 patients, with a detection rate of 3.02% (9/298). Among these genes, ZNF644 was the major gene of EOHM (1.67%, 5/298), whereas no mutations were identified in CTSH and LEPREL1. Collectively, these results suggested that the genetic defects responsible for most cases remain to be determined. Strikingly, we deciphered a significant rate of the genetic causes in these trios, supporting our initial hypothesis that EOHM is mainly driven by genetic predisposition.
Among the rare inherited biallelic mutations, three mutations were identified in the known genes GRM6, CACNA1F, and FAM161A that are responsible for inherited retinal dystrophy (IRD) (Dataset S1). Interestingly, HM occurs concomitantly in IRD patients with GRM6 or CACNA1F mutations (32, 62) . Our findings are consistent with a previous study showing that 23 .8% (71/298) of patients with EOHM actually harbor mutations in IRD genes (38) .
The role of de novo mutations in EOHM onset has never been explored. In this study, a total of 20 de novo mutations in the coding regions were validated in 12 EOHM probands. Interestingly, the de novo mutation rate was significantly elevated in the probands compared with that in the normal subjects (RR = 1.51, 1.11 vs. 0.74, P = 0.05), in particular damaging missense mutations (RR = 3.74, 0.39 vs. 0.1, P = 0.004). In addition, the de novo mutation rate was positively correlated with paternal age in this study (Fig. 1B) . Children's refractive changes decrease with parental reproductive age (63) , and thus, we speculate that the increased de novo mutation rate in the subjects with aged parents may be the underlying reason for the disease. In fact, we successfully identified several EOHM candidate genes with identified de novo mutations, such as BSG, EPHB2, CSMD1, and TENM4. These findings suggest that de novo mutations contribute substantially to the genetic etiology of EOHM.
The identification of recurrent de novo mutations serves as a useful method to identify disease-causing genes. However, we found that all of the de novo mutations occurred in different genes, which prevented us from performing a statistical analysis of these genes. Then, we searched the genes carrying damaging de novo missense mutations against the literature and found that none of them was associated with HM in previous reports, which can be explained by the fact that de novo mutations are extremely rare events that cannot be identified by GWAS or a linkage analysis. We subsequently asked whether there are any functional categories or cellular pathways enriched in this study. Despite the substantial genetic heterogeneity in HM, closely interconnected protein-protein interactions (PPIs) were identified by integrating the HM risk genes obtained from this and previous studies (Table   S4) . A gene ontology (GO) enrichment analysis showed that 43 of 62 genes were jointly clustered in four GO biological processes (Table S5 ). The results suggest that these genes play important roles in disease predisposition. The PPI analysis of these genes revealed a highly connected network, implying that EOHM is associated with visual perception, transcriptional regulation, and cell morphogenesis and homeostasis (Fig. 4) .
Among these genes with de novo mutations, we discovered a de novo mutation in a unique gene, BSG, in patient H13, and identified three different BSG mutations in an expanded screen of 1,040 patients with HM. We further verified its functional impact by generating knockin mice carrying the same BSG mutation identified in the first EOHM patient. Strikingly, the mutant mice displayed the myopic feature of an enlarged AL. In addition, our results showed that the spatial expression pattern of Bsg is similar to other known genes, such as Sco2 and Sntb1 (64, 65) . BSG encodes basigin, which is associated with retinal development and function. A previous study showed that Bsg KO mice led to defective function and photoreceptor degeneration in the retina (58, 59) . Interestingly, Basigin plays an important role in mediating the binding of rod-derived cone viability factor (RdCVF) to the glucose transporter GLUT1, which increases glucose influx into cone photoreceptors (66) . This evidence indicated that the retina might be one of the disease target tissues in EOHM driven by the BSG mutation. In this study, the Bsg mutant mice displayed the typical HM phenotypes with AL. As AL is responsible for myopia development (67), our results indicate that the Bsg mutation predisposed typical myopic phenotypes.
In summary, we performed a trio-based study to genetically dissect EOHM using next-generation sequencing and deciphered an important role for de novo mutations in this disease. The discovery of a disease gene, BSG, provides insight into myopia development and etiology, which expands our current understanding of HM and might be useful for future treatment and prevention.
Methods
The human subjects were recruited from The Eye Hospital of Wenzhou Medical University in accordance with a protocol approved by the Ethics Committee of the hospital. Written informed consent was provided by the parents and on behalf of their children before the peripheral blood, and clinical data were collected from the myopia patients and their parents. The experimental procedures are described in detail in SI Methods. Fig. 4 . PPI of the HM genes. PPI network of the genes related to HM identified in this study and previous studies.
